Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jarad M Martin

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy PlanningSandeep K Gupta, Tahne Watson, Jim Denham, et al.
Journal of Medical Imaging and Radiation Oncology|January 17, 2018
Moderate hypofractionation for prostate cancer: A user's guideDavid I Pryor, Sandra L Turner, Keen Hun Tai, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2005
Towards individualised radiotherapy for Stage I seminomaJarad M Martin, Daryl Lim Joon, Nicole Ng, et al.
Head & Neck|January 10, 2009
Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approachJames E Jackson, Graeme J Dickie, Kirsty L Wiltshire, et al.
BJU International|January 24, 2018
A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancerAlison B Rutledge, Nicholas McLeod, Nicholas Mehan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Frontiers in Oncology|September 5, 2024
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment dataStephen Morrell, David Roder, David Currow, et al.
European Urology Oncology|February 1, 2024
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre TrialEric Wegener, Mark Sidhom, David Pryor, et al.
JAMA Network Open|November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New ZealandDavid I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Radiation Oncology, Biology, Physics|December 28, 2017
Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography for Prostate Cancer: Distribution of Disease and Implications for Radiation Therapy PlanningSandeep K Gupta, Tahne Watson, Jim Denham, et al.
Journal of Medical Imaging and Radiation Oncology|January 17, 2018
Moderate hypofractionation for prostate cancer: A user's guideDavid I Pryor, Sandra L Turner, Keen Hun Tai, et al.
Radiation Oncology (London, England)|November 6, 2009
Image guided dose escalated prostate radiotherapy: still room to improveJarad M Martin, Andrew Bayley, Robert Bristow, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2005
Towards individualised radiotherapy for Stage I seminomaJarad M Martin, Daryl Lim Joon, Nicole Ng, et al.
Head & Neck|January 10, 2009
Radiotherapy for perineural invasion in cutaneous head and neck carcinomas: toward a risk-adapted treatment approachJames E Jackson, Graeme J Dickie, Kirsty L Wiltshire, et al.
BJU International|January 24, 2018
A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancerAlison B Rutledge, Nicholas McLeod, Nicholas Mehan, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2007
Phase II trial of hypofractionated image-guided intensity-modulated radiotherapy for localized prostate adenocarcinomaJarad M Martin, Tara Rosewall, Andrew Bayley, et al.
Frontiers in Oncology|September 5, 2024
Estimated incidence of disruptions to event-free survival from non-metastatic cancers in New South Wales, Australia - a population-wide epidemiological study of linked cancer registry and treatment dataStephen Morrell, David Roder, David Currow, et al.
European Urology Oncology|February 1, 2024
Prostate Virtual High-dose-rate Brachytherapy Boost: 5-Year Results from the PROMETHEUS Prospective Multicentre TrialEric Wegener, Mark Sidhom, David Pryor, et al.
JAMA Network Open|November 1, 2021
Evaluation of Hypofractionated Radiation Therapy Use and Patient-Reported Outcomes in Men With Nonmetastatic Prostate Cancer in Australia and New ZealandDavid I Pryor, Jarad M Martin, Jeremy L Millar, et al.
Pageof 4